DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Allyx Therapeutics, Inc.
Allyx Therapeutics, Inc.
Stage unknownNew Haven, CTBiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
2 rounds
- May 4, 2026Form D equity offering · $26.4M (form d sold) · 32 investorsFact SEC EDGAR Form D data sets (quarterly) · “Allyx Therapeutics, Inc. filed Form D: $26,427,730 sold of $29,999,999, Biotechnology”
- Feb 23, 2026Form D equity offering · $3.3M (form d sold) · 12 investorsFact SEC EDGAR Form D data sets (quarterly) · “Allyx Therapeutics, Inc. filed Form D: $3,324,918 sold of $4,000,000, Biotechnology”
Investors on record
1 edges
- ELM Street Venture Advisors, Inc. board only, Robert a. Bettigole (strongly supported) Inference sec.gov
People
3 officers, 5 directors
- Jennifer a Gabler Executive Officer sec.gov
- Stephen Bloch Executive Officer/Director sec.gov
- Timothy a Siegert Executive Officer sec.gov
- Kevin L. Rakin Director Fact
- Stephen Strittmatter Director Fact
- Robert a. Bettigole Director Inference
- Paul Fonteyne Director Fact
- Gregory P Ho Director Fact
Timeline
2
- May 11, 2026Allyx Therapeutics, Inc. filed Form D: $26,427,730 sold of $29,999,999, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Mar 3, 2026Allyx Therapeutics, Inc. filed Form D: $3,324,918 sold of $4,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company
- Entity type: Corporation May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $26.4M May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $3.3M Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $30.0M May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $4.0M Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-05-04 May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-02-23 Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 32 May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 12 Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity,option May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: option Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 555 Long Wharf Drive, Floor 11, NEW HAVEN, CT, 06511 May 11, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 555 Long Wharf Drive, Floor 11, NEW HAVEN, CT, 06511 Mar 3, 2026 Fact SEC EDGAR Form D data sets (quarterly)